QuantAbundanciaAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

22,423 signal articles · 134 in last 24h · 107,684 total before filter · latest 50m ago
134last 24h
2550last 7d
495● bullish (7d)
237● bearish (7d)
201publishers
AllMacro214Earnings1587M&A122Regulatory16Product10Analyst25
Sentiment:bullishneutralbearishshow all (incl. clickbait)
Investing.com5d agoneutral
Supernus jumps premarket on merger deal; GameStop drops

Investing.com - U.S. stock index futures advanced on Monday after President Donald Trump said negotiations with Iran were set to begin this week, easing geopolitical concerns that had rattled markets in recent weeks, while technology stocks attempted to extend their recovery following July’s sharp pullback.

Bloomberg5d agobullish
Dip Buyers Need to Heed the Market’s Warning Signs

(Bloomberg) -- The momentum trade just gave investors a taste of the pronounced profit-and-loss swings they can expect if they fail to hedge or diversify, a warning that’s reinforced by growing inflation risks. Most Read from BloombergTrump Says US to Hold Off Iran Attack If Deal AgreedSaudi Prince Concerned Over Trump’s Iran Strike Plan: AxiosTrump Says Iran Talks to Begin Monday After Scrapping AttackSingapore's Gated Island for the Rich Is Marred by Decayed HomesAlibaba Adds to China AI Break

If You Invested $5K in the SpaceX IPO, How Much Do You Have Now?
SmartAsset5d agoneutral
If You Invested $5K in the SpaceX IPO, How Much Do You Have Now?

SpaceX began trading on June 12, 2026, with an IPO price of $135 per share, giving retail investors an opportunity to buy into one of the world’s most closely watched aerospace companies. A $5,000 investment at the IPO price would have purchased about 37.04 shares. By June 16, those shares had climbed to $225.64, increasing […] The post If You Invested $5K in the SpaceX IPO, How Much Do You Have Now? appeared first on SmartReads by SmartAsset.

Bloomberg5d agobullish
KKR to Buy Device Maker Integer in $5.7 Billion Deal

(Bloomberg) -- KKR has agreed to buy US medical device company Integer Holdings Corp. in an all-cash deal valued at about $5.7 billion.Most Read from BloombergTrump Says US to Hold Off Iran Attack If Deal AgreedSaudi Prince Concerned Over Trump’s Iran Strike Plan: AxiosTrump Says Iran Talks to Begin Monday After Scrapping AttackSingapore's Gated Island for the Rich Is Marred by Decayed HomesAlibaba Adds to China AI Breakthroughs With New Qwen Model Integer stockholders will receive $127 per shar

Morgan Stanley uncovers major Bristol Myers stock signals
TheStreet5d agoneutral
Morgan Stanley uncovers major Bristol Myers stock signals

Bristol Myers Squibb (BMY) just gave investors a strong quarter and a bigger outlook. Morgan Stanley read the same report and kept its rating exactly where it was. (The source of much of this article is a Morgan Stanley report shared with me.) Morgan Stanley sees the stock falling to $40, well ...

Option Volatility And Earnings Report For Aug 3 - 7
Barchart5d agoneutral
Option Volatility And Earnings Report For Aug 3 - 7

It is another big week on the earnings front with a lots of big name companies reporting. This week could make or break the market. This week we have SpaceX, Advanced Micro Devices, Palantir Technologies, Sandisk, Uber Technologies, McDonald’s, Caterpillar, Merck & Company, Disney, Shopify and Arista Networks all reporting in what shapes as a busy and pivotal week for stocks.

🎢The One Constant in Korean Stocks? Volatility
The Wall Street Journal5d agoneutral
🎢The One Constant in Korean Stocks? Volatility

A crisis of confidence in the AI trade has dogged the index of late, putting it in bear market. Big swings, driven by SK Hynix and Samsung, which make chips crucial to the AI buildout and which together make up most of the Kospi, have become practically routine.

Health Care Roundup: Market Talk
The Wall Street Journal5d agoneutral
Health Care Roundup: Market Talk

Find insight on AstraZeneca , Bristol Myers Squibb, Hartalega and more in the latest Market Talks covering health care.